SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-122499
Filing Date
2024-04-29
Accepted
2024-04-29 16:32:59
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-29

Document Format Files

Seq Description Document Type Size
1 ARS d825228dars.pdf ARS 894829
  Complete submission text file 0001193125-24-122499.txt   1233835
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-37766 | Film No.: 24891548
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)